{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:08:12Z","timestamp":1792638492788,"version":"4.5.0"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2018.00284","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T01:45:54Z","timestamp":1539049554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["The Vasculopathy of Juvenile Dermatomyositis"],"prefix":"10.3389","volume":"6","author":[{"given":"Charalampia","family":"Papadopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza J.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.berh.2017.12.003","article-title":"Juvenile dermatomyositis: latest advances","volume":"31","author":"Wu","year":"2017","journal-title":"Best Prac Res Clin Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.berh.2009.07.007","article-title":"Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment","volume":"23","author":"Wedderburn","year":"2009","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJM197202172860701","article-title":"Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy","volume":"286","author":"Whitaker","year":"1972","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/art.1780250203","article-title":"Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis","volume":"25","author":"Crowe","year":"1982","journal-title":"Arthr Rheum"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis national registry and repository (UK and Ireland)\u2013clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/art.1780300513","article-title":"Activation of complement and coagulation in juvenile dermatomyositis","volume":"30","author":"Scott","year":"1987","journal-title":"Arthr Rheum"},{"key":"B10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthr Rheum"},{"key":"B11","first-page":"801","article-title":"Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis","volume":"31","author":"Sallum","year":"2004","journal-title":"J Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1002\/art.21303","article-title":"Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy","volume":"52","author":"Fall","year":"2005","journal-title":"Arthr Rheum"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1740-2557-3-2","article-title":"Endothelial cell activation and neovascularization are prominent in dermatomyositis","volume":"3","author":"Nagaraju","year":"2006","journal-title":"J Autoimmune Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.22558","article-title":"Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis","volume":"56","author":"Lopez de Padilla","year":"2007","journal-title":"Arthr Rheum"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthr Rheum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/art.22993","article-title":"Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients","volume":"57","author":"Miles","year":"2007","journal-title":"Arthr Rheum"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/art.23012","article-title":"International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials","volume":"57","author":"Wedderburn","year":"2007","journal-title":"Arthr Rheum"},{"key":"B18","first-page":"1198","article-title":"Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children","volume":"25","author":"Pachman","year":"1998","journal-title":"J Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","article-title":"The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis","volume":"16","author":"Hoeltzel","year":"2014","journal-title":"Curr Rheumatol Rep."},{"key":"B20","unstructured":"Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies DuganEM HuberAM MillerFW RiderLG International MyositisA Clinical StudiesG 19336019Dermatol Online J.2009"},{"key":"B21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/art.22782","article-title":"Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy","volume":"57","author":"Mamyrova","year":"2007","journal-title":"Arthr Rheum"},{"key":"B22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0022-3476(80)80807-9","article-title":"Juvenile dermatomyositis: a clinical and immunologic study","volume":"96","author":"Pachman","year":"1980","journal-title":"J Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","article-title":"Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification","volume":"103","author":"Bowyer","year":"1983","journal-title":"J Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/BOR.0b013e328331927e","article-title":"Juvenile dermatomyositis: extramuscular manifestations and their management","volume":"21","author":"Lowry","year":"2009","journal-title":"Curr Opin Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1067\/mpd.2001.113363","article-title":"Juvenile dermatomyositis presenting with anasarca: a possible indicator of severe disease activity","volume":"138","author":"Mitchell","year":"2001","journal-title":"J Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthr Rheum"},{"key":"B28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.51.3.378","article-title":"Staphylococcal infections in childhood dermatomyositis\u2013association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect","volume":"51","author":"Moore","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/art.1780250807","article-title":"Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis","volume":"25","author":"Spencer-Green","year":"1982","journal-title":"Arthr Rheum"},{"key":"B30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/art.23299","article-title":"Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis","volume":"58","author":"Christen-Zaech","year":"2008","journal-title":"Arthr Rheum"},{"key":"B31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/rheumatology\/kev359","article-title":"Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis","volume":"55","author":"Gitiaux","year":"2016","journal-title":"Rheumatology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm062850","article-title":"Images in clinical medicine","author":"Rider","year":"2009","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1136\/annrheumdis-2013-203279","article-title":"In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity","volume":"73","author":"Schwartz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/rheumatology\/kev376","article-title":"In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13","volume":"55","author":"Barth","year":"2016","journal-title":"Rheumatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00415-014-7623-1","article-title":"Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography","volume":"262","author":"Rosenbohm","year":"2015","journal-title":"J Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","author":"Schwartz","year":"2016","journal-title":"RMD Open"},{"key":"B37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jpeds.2011.05.015","article-title":"Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis","volume":"159","author":"Eimer","year":"2011","journal-title":"J Pediatr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthr Rheum"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1161\/ATVBAHA.109.190108","article-title":"Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study","volume":"29","author":"Stamatelopoulos","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3899\/jrheum.090061","article-title":"Arterial events in persons with dermatomyositis and polymyositis","volume":"36","author":"Tisseverasinghe","year":"2009","journal-title":"J Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e33442","DOI":"10.1371\/journal.pone.0033442","article-title":"Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"7","author":"Zaller","year":"2012","journal-title":"PLoS ONE"},{"key":"B43","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/rheumatology\/kex465","article-title":"Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample","volume":"57","author":"Silverberg","year":"2018","journal-title":"Rheumatology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/archsurg.1988.01400330093014","article-title":"Required surgical therapy in the pediatric patient with dermatomyositis","volume":"123","author":"Downey","year":"1988","journal-title":"Arch Surg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0022-3476(99)70137-X","article-title":"Novel gastrointestinal tract manifestations in juvenile dermatomyositis","volume":"135","author":"Laskin","year":"1999","journal-title":"J Pediatr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/rheumatology\/keg040","article-title":"Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A","volume":"42","author":"Kobayashi","year":"2003","journal-title":"Rheumatology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/ar3097","article-title":"Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management","author":"Castelino","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/rheumatology\/40.2.216","article-title":"Pulmonary involvement in juvenile dermatomyositis: a two-year longitudinal study","volume":"40","author":"Trapani","year":"2001","journal-title":"Rheumatology"},{"key":"B49","first-page":"723","article-title":"Fatal pulmonary involvement in dermatomyositis","volume":"129","author":"Park","year":"1975","journal-title":"Am J Dis Child."},{"key":"B50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1590\/S0482-50042009000400012","article-title":"Juvenile dermatomyositis (JDM) and severe pulmonary involvement: case report","volume":"49","author":"Carneiro da SilvaI","year":"2009","journal-title":"Rev Bras Reumatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1111\/j.1756-185X.2011.01603.x","article-title":"Spontaneous pneumomediastinum: a rare complication of juvenile dermatomyositis","volume":"15","author":"Dogra","year":"2012","journal-title":"Int J Rheum Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/ard.59.5.372","article-title":"Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy","volume":"59","author":"Kono","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4274\/balkanmedj.2016.1061","article-title":"Amyopathic Dermatomyositis associated with histopathological findings of organizing pneumonia and pulmonary vasculitis","volume":"34","author":"Lim","year":"2017","journal-title":"Balkan Med J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/rheumatology\/40.11.1293","article-title":"Central nervous system complications in two cases of juvenile onset dermatomyositis","volume":"40","author":"Ramanan","year":"2001","journal-title":"Rheumatology"},{"key":"B55","first-page":"2059","article-title":"Case report: severe central nervous system involvement in juvenile dermatomyositis","volume":"30","author":"Elst","year":"2003","journal-title":"J Rheumatol."},{"key":"B56","first-page":"1986","article-title":"Eye findings in patients with juvenile dermatomyositis","volume":"32","author":"Akikusa","year":"2005","journal-title":"J Rheumatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/BOR.0000000000000224","article-title":"Comparing and contrasting clinical and serological features of juvenile and adult-onset myositis: implications for pathogenesis and outcomes","volume":"27","author":"Tansley","year":"2015","journal-title":"Curr Opin Rheumatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthr Rheum"},{"key":"B60","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar4600","article-title":"Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study","volume":"16","author":"Tansley","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/rheumatology\/kex468","article-title":"Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics","volume":"57","author":"Karasawa","year":"2018","journal-title":"Rheumatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.20452\/pamw.306","article-title":"Vasculopathy and vasculitis in systemic lupus erythematosus","volume":"118","author":"Cieslik","year":"2008","journal-title":"Pol Arch Med Wewn."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in Juvenile Dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3899\/jrheum.090953","article-title":"Treatment approaches to juvenile dermatomyositis (JDM) across North America: the childhood arthritis and rheumatology research alliance (CARRA) JDM treatment survey","volume":"37","author":"Stringer","year":"2010","journal-title":"J Rheumatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-016-0134-0","article-title":"Childhood arthritis and rheumatology research alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease","volume":"15","author":"Kim","year":"2017","journal-title":"Pediatr Rheum."},{"key":"B66","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3899\/jrheum.160688","article-title":"Childhood arthritis and rheumatology research alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash","volume":"44","author":"Huber","year":"2017","journal-title":"J Rheumatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/art.24571","article-title":"Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment","volume":"60","author":"Kim","year":"2009","journal-title":"Arthr Rheum"},{"key":"B71","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/art.23341","article-title":"Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis","volume":"59","author":"Rouster-Stevens","year":"2008","journal-title":"Arthr Rheum"},{"key":"B72","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/art.23829","article-title":"The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis","volume":"59","author":"Seshadri","year":"2008","journal-title":"Arthr Rheum"},{"key":"B73","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4137\/CCRPM.S23313","article-title":"Recent treatment of interstitial lung disease with idiopathic inflammatory myopathies","volume":"9","author":"Kawasumi","year":"2015","journal-title":"Clin Med"},{"key":"B75","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1542\/peds.59.2.212","article-title":"Methotrexate and azathioprine treatment of childhood dermatomyositis","volume":"59","author":"Jacobs","year":"1977","journal-title":"Pediatrics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthr Rheum"},{"key":"B77","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/art.37758","article-title":"The efficacy of rituximab in refractory myositis: the jury is still out","volume":"65","author":"de Visser","year":"2013","journal-title":"Arthr Rheum"},{"key":"B78","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology"},{"key":"B79","first-page":"1708","article-title":"Efficacy and safety of tumour necrosis factor antagonists in a large cohort of juvenile dermatomyositis patients [abstract]","volume":"68","author":"Campanilho-Marques","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/s0093-3619(08)70497-0","article-title":"Use of etanercept in the treatment of dermatomyositis: a case series","volume":"33","author":"Iannone","year":"2006","journal-title":"J Rheumatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/acr.22198","article-title":"Pilot study of etanercept in patients with refractory juvenile dermatomyositis","volume":"66","author":"Rouster-Stevens","year":"2014","journal-title":"Arthritis Care Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","volume":"146","author":"Klein","year":"2010","journal-title":"Arch Dermatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamadermatol.2013.5220","article-title":"Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis","volume":"149","author":"Liu","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","article-title":"Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis","volume":"160","author":"Arabshahi","year":"2012","journal-title":"J Pediatr."},{"key":"B85","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/rheumatology\/keh082","article-title":"Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis","volume":"43","author":"Riley","year":"2004","journal-title":"Rheumatology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/art.40418","article-title":"Efficacy and safety of cyclophosphamide treatment in severe juvenile dermatomyositis shown by marginal structural modeling","volume":"70","author":"Deakin","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1002\/art.34659","article-title":"Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course","volume":"64","author":"Reed","year":"2012","journal-title":"Arthr Rheum"},{"key":"B88","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/jamadermatol.2016.0866","article-title":"Tofacitinib citrate for refractory cutaneous dermatomyositis: an alternative treatment","volume":"152","author":"Kurtzman","year":"2016","journal-title":"JAMA Dermatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/1759720X11424460","article-title":"Juvenile dermatomyositis: new insights and new treatment strategies","volume":"4","author":"Martin","year":"2012","journal-title":"Ther Adv Musculoskelet Dis."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00284\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T12:47:37Z","timestamp":1662209257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00284\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":89,"alternative-id":["10.3389\/fped.2018.00284"],"URL":"https:\/\/doi.org\/10.3389\/fped.2018.00284","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]},"article-number":"284"}}